ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson's disease.

Marta Garcia-Gomara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.